Ahmed, AM, et al.
Genetic characterization of multidrug resistance in Shigella sp. from Japan. Journal of Medical Microbiology
2006; 55: 1685–1691.
Kotloff, KL, et al.
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization
1999; 77: 651–666.
World Health Organization. Shigellosis: disease burden, epidemiology and case management. Weekly Epidemiological Record
2005; 80: 94–99.
Christopher, PR, et al.
Antibiotic therapy for Shigella dysentery. Cochrane Database of Systematic Reviews
2010. Issue 1, Art. No.: CD006784.
Ashkenazi, S, et al.
Growing antimicrobial resistance of Shigella isolates. Journal of Antimicrobial Chemotherapy
2003; 51: 427–429.
Bennish, ML, Salam, MA. Rethinking options for the treatment of shigellosis. Journal of Antimicrobial Chemotherapy
1992; 30: 243–247.
Zafar, A, et al.
Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan. International Journal of Infectious Disease
2009; 13: 668–672.
Ghosh, AR, Sehgal, SC. Existing status of shigellosis in Andaman & Nicobar Islands. Indian Journal of Medical Research
1996; 103: 134–137.
Ghosh, AR, Sehgal, SC. Shigella infections among children in Andaman – an archipelago of tropical islands in Bay of Bengal. Epidemiology and Infection
1998; 121: 43–48.
Roy, S, et al.
Distribution of Shigella enterotoxin genes and secreted autotransporter toxin gene among diverse species and serotypes of Shigella isolated from Andaman Islands, India. Tropical Medicine and International Health
2006; 11: 1694–1698.
World Health Organization. Manual for Laboratory Investigation of Acute Enteric Infections, 1987; CDD/83.3. Geneva, Switzerland: World Health Organization.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty Second Informational Supplement, M100–S22, 2012; Wayne, PA, USA: Clinical and Laboratory Standards Institute.
Bhattacharya, D, et al.
Rapid emergence of third generation cephalosporin resistance in Shigella sp. isolated in Andaman and Nicobar Islands, India. Microbial Drug Resistance
2011; 17: 329–32.
Greenhill, C. Infectious disease: Genome sequencing reveals how Shigella sonnei spread around the world. Nature Reviews Gastroenterology and Hepatology
2012; 9: 487.
Dutta, S, et al.
Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of Shigella strains isolated from Kolkata, India during 1995–2000. Epidemiology and Infection
2002; 129: 235–243.
Khan, AI, et al.
Shigella serotypes among hospitalized patients in urban Bangladesh and their antimicrobial resistance. Epidemiology and Infection
2004; 132: 773–777.
Vasilev, V, et al.
Variability of Shigella flexneri serotypes in Israel during a period of two years: 2000 and 2001. Epidemiology and Infection
2004; 132: 51–56.
Farshad, S, et al.
Characterization of Shigella strains in Iran by plasmid profile analysis and PCR amplification of ipa genes. Journal of Clinical Microbiology
2006; 44: 2879–83.
Von, Seidlein L, et al.
A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations and microbiology. PLoS Medicine
2006; 3: e353.
Niyogi, SK, et al.
Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India. Japanese Journal of Infectious Disease
2001; 54: 121–122.
Ghosh, AR, et al.
Emergence of nalidixic acid-resistant Shigella sonnei in acute-diarrhoea patients on Andaman & Nicobar Islands, India. Antimicrobial Agents and Chemotherapy
2003; 47: 1483.
Naheed, A, et al.
Fluoroquinolone resistant Shigella dysenteriae type 1 in northeastern Bangladesh. Lancet Infectious Disease
2004; 4: 607–608.
Hirose, K, et al.
Antimicrobial susceptibility of Shigella sonnei isolates in Japan and molecular analysis of S. sonnei isolates with reduced susceptibility to fluoroquinolones. Antimicrobial Agents and Chemotherapy
2005; 49: 1203–1205.
Roy, S, et al.
Emergence of fluoroquinolone resistance in Shigella isolated from Andaman & Nicobar Islands, India. Indian Journal of Medical Research
2010; 131: 720–722.
Okeke, IN, et al.
Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infectious Disease
2005; 5: 481–493.
Bhattacharya, D, et al.
Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011. European Journal of Clinical Microbiology and Infectious Diseases
2013; 33: 157–170.
Yadav, P. Countering drug resistance in the developing world: an 11 assessment across the value chain and recommendations for policy interventions. Working Paper 183. Center for Global Development, 2009 (www.cgdev.org/content/publications/detail/1422842).
Costelloe, C, et al.
Effect of antibiotic 12 prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. British Medical Journal
2010; 340: 2096.
So, AD, et al.
Tackling antibiotic resistance: concerted action is needed to provide new technologies and conserve existing drugs. British Medical Journal
2010; 340: c2071.